BIMZELX

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Poland, Romania, United Kingdom, United States

Active ingredients

The drug BIMZELX contains one active pharmaceutical ingredient (API):

1 Bimekizumab UNII 09495UIM6V - BIMEKIZUMAB

Bimekizumab is a humanised IgG1/κ monoclonal antibody that selectively binds with high affinity to IL-17A, IL-17F and IL-17AF cytokines, blocking their interaction with the IL-17RA/IL-17RC receptor complex. Elevated concentrations of IL-17A and IL-17F have been implicated in the pathogenesis of several immune-mediated inflammatory diseases including plaque psoriasis. Read about Bimekizumab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BIMZELX Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AC21		L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AC Interleukin inhibitors
Discover more medicines within L04AC21

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02525267, 02525275
Country: EE	Ravimiamet	Identifier(s): 1860858, 1860869, 1860870, 1860881, 1860892, 1860904, 1860915, 1860926
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1211575002, 1211575006
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 142295
Country: FR	Base de données publique des médicaments	Identifier(s): 62412256, 68708415
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9195
Country: IT	Agenzia del Farmaco	Identifier(s): 049693017, 049693029, 049693031, 049693043, 049693056, 049693068, 049693070, 049693082
Country: JP	医薬品医療機器総合機構	Identifier(s): 3999464G1020, 3999464G2026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1093225, 1093226, 1093227, 1093228, 1093229, 1093230, 1093231, 1093232
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100457660, 100457678
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68773001
Country: US	FDA, National Drug Code	Identifier(s): 50474-780, 50474-781